131 related articles for article (PubMed ID: 19506402)
1. Expression of DLC-1 in clear cell renal cell carcinoma: prognostic significance for progression and metastasis.
Zhang T; Zheng J; Liu C; Lu Y
Urol Int; 2009; 82(4):380-7. PubMed ID: 19506402
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma.
Zhang T; Zheng J; Jiang N; Wang G; Shi Q; Liu C; Lu Y
Cancer Lett; 2009 Sep; 283(1):59-67. PubMed ID: 19380190
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of HNF-1B in renal cell carcinoma is associated with tumor progression and poor prognosis.
Buchner A; Castro M; Hennig A; Popp T; Assmann G; Stief CG; Zimmermann W
Urology; 2010 Aug; 76(2):507.e6-11. PubMed ID: 20538322
[TBL] [Abstract][Full Text] [Related]
4. Significance of Fas expression alteration during tumor progression of renal cell carcinoma.
Sejima T; Miyagawa I
Int J Urol; 2006 Mar; 13(3):257-64. PubMed ID: 16643620
[TBL] [Abstract][Full Text] [Related]
5. The expression of prostate stem cell antigen in human clear cell renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis.
Elsamman EM; Fukumori T; Tanimoto S; Nakanishi R; Takahashi M; Toida K; Kanayama HO
BJU Int; 2006 Sep; 98(3):668-73. PubMed ID: 16925770
[TBL] [Abstract][Full Text] [Related]
6. Expression of aquaporin 1 in primary renal tumors: a prognostic indicator for clear-cell renal cell carcinoma.
Huang Y; Murakami T; Sano F; Kondo K; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
Eur Urol; 2009 Oct; 56(4):690-8. PubMed ID: 18930582
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.
Ohno Y; Izumi M; Yoshioka K; Ohori M; Yonou H; Tachibana M
Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899
[TBL] [Abstract][Full Text] [Related]
8. Biologic significance of fascin expression in clear cell renal cell carcinoma: systematic analysis of primary and metastatic tumor tissues using a tissue microarray technique.
Zigeuner R; Droschl N; Tauber V; Rehak P; Langner C
Urology; 2006 Sep; 68(3):518-22. PubMed ID: 16979727
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
Miyata Y; Iwata T; Ohba K; Kanda S; Nishikido M; Kanetake H
Clin Cancer Res; 2006 Dec; 12(23):6998-7003. PubMed ID: 17145820
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H
Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor-2alpha mRNA expression in human renal cell carcinoma.
Sandlund J; Ljungberg B; Wikström P; Grankvist K; Lindh G; Rasmuson T
Acta Oncol; 2009; 48(6):909-14. PubMed ID: 19322701
[TBL] [Abstract][Full Text] [Related]
12. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
Meyer HA; Tölle A; Jung M; Fritzsche FR; Haendler B; Kristiansen I; Gaspert A; Johannsen M; Jung K; Kristiansen G
Eur Urol; 2009 Mar; 55(3):669-78. PubMed ID: 18450365
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
[TBL] [Abstract][Full Text] [Related]
14. Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma.
Kawata N; Nagane Y; Hirakata H; Ichinose T; Okada Y; Yamaguchi K; Takahashi S
Urology; 2007 Jun; 69(6):1049-53. PubMed ID: 17572184
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma.
Romero JM; Aptsiauri N; Vazquez F; Cozar JM; Canton J; Cabrera T; Tallada M; Garrido F; Ruiz-Cabello F
Tissue Antigens; 2006 Oct; 68(4):303-10. PubMed ID: 17026465
[TBL] [Abstract][Full Text] [Related]
16. Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma.
Thompson RH; Gillett MD; Cheville JC; Lohse CM; Dong H; Webster WS; Chen L; Zincke H; Blute ML; Leibovich BC; Kwon ED
Cancer; 2005 Nov; 104(10):2084-91. PubMed ID: 16208700
[TBL] [Abstract][Full Text] [Related]
17. Increased interferon alpha receptor 2 mRNA levels is associated with renal cell carcinoma metastasis.
Kamai T; Yanai Y; Arai K; Abe H; Yamanishi T; Kurimoto M; Yoshida K
BMC Cancer; 2007 Aug; 7():159. PubMed ID: 17697365
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma.
Betsunoh H; Mukai S; Akiyama Y; Fukushima T; Minamiguchi N; Hasui Y; Osada Y; Kataoka H
Cancer Sci; 2007 Apr; 98(4):491-8. PubMed ID: 17309599
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
[TBL] [Abstract][Full Text] [Related]
20. Altered messenger RNA and protein expressions for insulin-like growth factor family members in clear cell and papillary renal cell carcinomas.
Cheung C; Vesey D; Cotterill A; Douglas M; Gobe G; Nicol D; Johnson D
Int J Urol; 2005 Jan; 12(1):17-28. PubMed ID: 15661050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]